• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385100
Device Problem Leak/Splash (1354)
Patient Problem Foreign Body In Patient (2687)
Event Date 11/16/2020
Event Type  Injury  
Manufacturer Narrative
Medical device expiration date: unknown.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.(b)(4).
 
Event Description
It was reported that the septum of the bd q-syte¿ luer access split-septum stand-alone device came unglued and was drawn into the body.The following information was provided by the initial reporter: "some of split septum was drawn into body".
 
Manufacturer Narrative
The following fields were updated due to additional information: d.10.Device available for eval?: yes d.10.Returned to manufacturer on: 12/3/2020 h.6.Investigation: our quality engineer inspected the samples and photographs submitted for evaluation.Bd received two photographs displaying two different views of a q-syte unit without packaging with septum pushed into the top body of the q-syte.In addition, one used unit was received which revealed similarities to that of the provided photos.Upon microscopic evaluation of the unit, it is confirmed that there are residual septum material and adhesive deposits on the rim of the top body (polycarbonate) and top disk, which indicate a sufficient bond at the time of manufacture.There were no signs of a column wall tear.A water leak test was performed where leakage was observed in the unactuated position at the top slit.This leak is likely due to the damage observed to the septum.Although the reported issue was confirmed, it could not be determined if the damage resulted from the manufacturing of the device or from the user environment.See h.10.
 
Event Description
It was reported that the septum of the bd q-syte¿ luer access split-septum stand-alone device came unglued and was drawn into the body.The following information was provided by the initial reporter: "some of split septum was drawn into body".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
MDR Report Key10997409
MDR Text Key221234585
Report Number9610847-2020-00410
Device Sequence Number1
Product Code FPA
UDI-Device Identifier30382903851004
UDI-Public30382903851004
Combination Product (y/n)N
PMA/PMN Number
K013621
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 03/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number385100
Device Catalogue Number385100
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/03/2020
Date Manufacturer Received03/01/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-